Ingrid Gause-Nilsson

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study

2011 | 3. lékařská fakulta

Publikace